137 related articles for article (PubMed ID: 30922374)
1. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
[TBL] [Abstract][Full Text] [Related]
2. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
3. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
Li L; Shao MY; Zou SC; Xiao ZF; Chen ZC
J Neurooncol; 2019 Jan; 141(1):19-30. PubMed ID: 30539341
[TBL] [Abstract][Full Text] [Related]
4. The AKT/mTOR Signaling Pathway Was Mediated through the LINC00514/miR-28-5p/TRIM44 Axis.
Wu L; Zhu X; Wang R; Sun S; Ma B; Zhang Z
Dis Markers; 2022; 2022():1889467. PubMed ID: 36193506
[TBL] [Abstract][Full Text] [Related]
5. Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.
Ong CA; Shannon NB; Ross-Innes CS; O'Donovan M; Rueda OM; Hu DE; Kettunen MI; Walker CE; Noorani A; Hardwick RH; Caldas C; Brindle K; Fitzgerald RC
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777112
[TBL] [Abstract][Full Text] [Related]
6. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.
Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
8. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway.
Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B
Mol Cancer; 2024 Feb; 23(1):34. PubMed ID: 38360682
[TBL] [Abstract][Full Text] [Related]
9. GABARAP suppresses EMT and breast cancer progression via the AKT/mTOR signaling pathway.
Liu Y; Wang D; Lei M; Gao J; Cui Y; Jin X; Yu Q; Jiang Y; Guo Y; Liu Y; Cai L; Chen X
Aging (Albany NY); 2021 Feb; 13(4):5858-5874. PubMed ID: 33591943
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT-mTOR pathway.
Wang J; Cheng Z; Dai D; Li H; Shao X; Xu M
Mol Carcinog; 2023 Sep; 62(9):1325-1337. PubMed ID: 37212497
[TBL] [Abstract][Full Text] [Related]
11. PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the AKT/mTOR signaling pathway.
Chen H; Li L; Liu H; Qin P; Chen R; Liu S; Xiong H; Li Y; Yang Z; Xie M; Yang H; Jiang Q
J Pathol; 2024 Apr; 262(4):467-479. PubMed ID: 38185904
[TBL] [Abstract][Full Text] [Related]
12. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract][Full Text] [Related]
13. SPI1 involvement in malignant melanoma pathogenesis by regulation of HK2 through the AKT1/mTOR pathway.
Liu C; Qiu X; Gao J; Gong Z; Zhou X; Luo H; Geng X
J Cell Mol Med; 2023 Sep; 27(18):2675-2683. PubMed ID: 37539493
[TBL] [Abstract][Full Text] [Related]
14. Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
Fu XQ; Liu B; Wang YP; Li JK; Zhu PL; Li T; Tse KW; Chou JY; Yin CL; Bai JX; Liu YX; Chen YJ; Yu ZL
Cell Death Dis; 2020 Apr; 11(4):246. PubMed ID: 32312954
[TBL] [Abstract][Full Text] [Related]
15. Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.
Okada T; Lee AY; Qin LX; Agaram N; Mimae T; Shen Y; O'Connor R; López-Lago MA; Craig A; Miller ML; Agius P; Molinelli E; Socci ND; Crago AM; Shima F; Sander C; Singer S
Cancer Discov; 2016 Oct; 6(10):1148-1165. PubMed ID: 27577794
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.
Cai H; Zhao J; Zhang Q; Wu H; Sun Y; Guo F; Zhou Y; Qin G; Xia W; Zhao Y; Liang X; Yin S; Qin Y; Li D; Wu H; Ren D
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167183. PubMed ID: 38657551
[TBL] [Abstract][Full Text] [Related]
17. Loureirin A Promotes Cell Differentiation and Suppresses Migration and Invasion of Melanoma Cells via WNT and AKT/mTOR Signaling Pathways.
Xia ZY; Liu L; Kuok CF; Wang XL; Shi D; Ma Q; Cheng XY; Wang GL; Li MJ; Zheng QS; Liu XN; Li DF; Li BH
Biol Pharm Bull; 2024 Feb; 47(2):486-498. PubMed ID: 38199251
[TBL] [Abstract][Full Text] [Related]
18. Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1.
Zhong Q; Wang HG; Yang JH; Tu RH; Li AY; Zeng GR; Zheng QL; Yu Liu Z; Shang-Guan ZX; Bo Huang X; Huang Q; Li YF; Zheng HL; Lin GT; Huang ZN; Xu KX; Qiu WW; Jiang MC; Zhao YJ; Lin JX; Huang ZH; Huang JM; Li P; Xie JW; Zheng CH; Chen QY; Huang CM
Adv Sci (Weinh); 2023 Nov; 10(32):e2301977. PubMed ID: 37824217
[TBL] [Abstract][Full Text] [Related]
19. Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer.
Qiu S; Qiu Y; Deng L; Nie L; Ge L; Zheng X; Jin D; Jin K; Zhou X; Su X; Cai B; Li J; Tu X; Gong L; Liu L; Liu Z; Bao Y; Ai J; Lin T; Yang L; Wei Q
Chin Med J (Engl); 2024 Jan; 137(2):209-221. PubMed ID: 37390491
[TBL] [Abstract][Full Text] [Related]
20. XTP8 Promotes Ovarian Cancer Progression by Activating AKT/AMPK/mTOR Pathway to Regulate EMT.
Zhao R; Ning X; Lu H; Xu W; Ma J; Cheng J; Ma R
Cell Biochem Biophys; 2024 Mar; ():. PubMed ID: 38717641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
